No Data
No Data
Fosun Pharmaceutical 2024 Annual Report
Fosun Pharmaceutical 2024 Annual Report Summary
Express News | Shanghai Fosun Pharmaceutical Group FY Operating Cash Flow RMB 4,477 Million
Express News | Shanghai Fosun Pharmaceutical Group FY Revenue RMB 40,910 Million
FOSUN PHARMA: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024
FOSUN PHARMA (02196) released its 2024 annual report: Accelerating the internationalization of innovative products, with cash flow from operations increasing by 31.13% year-on-year.
On March 25, FOSUN PHARMA released the 2024 annual performance report.